← Leaderboards
Collin David Heer
University Of Iowa
$442,494
Attributed
$442,494
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $101K · FY2019–24$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$442,494 · 2
By mechanism
K00$377,938 · 1
F99$64,556 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Garry R Buettner$6,434,018
- Joseph J Cullen$5,964,157
- Frederick E Domann$2,914,825
- Larry Oberley$2,739,948
- Donald D Heistad$11,093,459
Others in their field
Other Emerging Leaders on “Effectiveness”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Leonard Freedman · Leidos Biomedical Research, Inc.$90,203,558
Research focus
EffectivenessEnzymesAdenosineDoctor Of PhilosophyBiologyAntioxidant EnzymeCancer CellAtaxia Telangiectasia Mutated ProteinAwardAccountingCellsCessation Of LifeChemoradiationBiomedical ResearchChemosensitizing AgentChemotherapyComplexCytotoxicCareerDiagnosisDna DamageCell DeathDna RepairExhibits
Grant awards (6)
Elucidating and exploiting NAD metabolic defects in cancer$101,003
K00 · FY2024 · CA · contact PI
Elucidating and exploiting NAD metabolic defects in cancer$96,387
K00 · FY2023 · CA · contact PI
Elucidating and exploiting NAD metabolic defects in cancer$91,772
K00 · FY2022 · CA · contact PI
Elucidating and exploiting NAD metabolic defects in cancer$88,776
K00 · FY2021 · CA · contact PI
Selective targeting of tumor cell redox metabolism and DNA damage responses to enhance cancer therapy$31,780
F99 · FY2020 · CA · contact PI
Selective targeting of tumor cell redox metabolism and DNA damage responses to enhance cancer therapy$32,776
F99 · FY2019 · CA · contact PI